RATIONALE: Formation of heart valves requires early endocardial to mesenchymal transformation (EMT) to generate valve mesenchyme and subsequent endocardial cell proliferation to elongate valve leaflets. Nfatc1 (nuclear factor of activated T cells, cytoplasmic 1) is highly expressed in valve endocardial cells and is required for normal valve formation, but its role in the fate of valve endocardial cells during valve development is unknown. OBJECTIVE: Our aim was to investigate the function of Nfatc1 in cell-fate decision making by valve endocardial cells during EMT and early valve elongation. METHODS AND RESULTS: Nfatc1 transcription enhancer was used to generate a novel valve endocardial cell-specific Cre mouse line for fate-mapping analyses of valve endocardial cells. The results demonstrate that a subpopulation of valve endocardial cells marked by the Nfatc1 enhancer do not undergo EMT. Instead, these cells remain within the endocardium as a proliferative population to support valve leaflet extension. In contrast, loss of Nfatc1 function leads to enhanced EMT and decreased proliferation of valve endocardium and mesenchyme. The results of blastocyst complementation assays show that Nfatc1 inhibits EMT in a cell-autonomous manner. We further reveal by gene expression studies that Nfatc1 suppresses transcription of Snail1 and Snail2, the key transcriptional factors for initiation of EMT. CONCLUSIONS: These results show that Nfatc1 regulates the cell-fate decision making of valve endocardial cells during valve development and coordinates EMT and valve elongation by allocating endocardial cells to the 2 morphological events essential for valve development.
RATIONALE: Formation of heart valves requires early endocardial to mesenchymal transformation (EMT) to generate valve mesenchyme and subsequent endocardial cell proliferation to elongate valve leaflets. Nfatc1 (nuclear factor of activated T cells, cytoplasmic 1) is highly expressed in valve endocardial cells and is required for normal valve formation, but its role in the fate of valve endocardial cells during valve development is unknown. OBJECTIVE: Our aim was to investigate the function of Nfatc1 in cell-fate decision making by valve endocardial cells during EMT and early valve elongation. METHODS AND RESULTS:Nfatc1 transcription enhancer was used to generate a novel valve endocardial cell-specific Cre mouse line for fate-mapping analyses of valve endocardial cells. The results demonstrate that a subpopulation of valve endocardial cells marked by the Nfatc1 enhancer do not undergo EMT. Instead, these cells remain within the endocardium as a proliferative population to support valve leaflet extension. In contrast, loss of Nfatc1 function leads to enhanced EMT and decreased proliferation of valve endocardium and mesenchyme. The results of blastocyst complementation assays show that Nfatc1 inhibits EMT in a cell-autonomous manner. We further reveal by gene expression studies that Nfatc1 suppresses transcription of Snail1 and Snail2, the key transcriptional factors for initiation of EMT. CONCLUSIONS: These results show that Nfatc1 regulates the cell-fate decision making of valve endocardial cells during valve development and coordinates EMT and valve elongation by allocating endocardial cells to the 2 morphological events essential for valve development.
Authors: Aaron D Gitler; Yuan Zhu; Fraz A Ismat; Min Min Lu; Yasutaka Yamauchi; Luis F Parada; Jonathan A Epstein Journal: Nat Genet Date: 2002-12-09 Impact factor: 38.330
Authors: Ching-Pin Chang; Joel R Neilson; J Henri Bayle; Jason E Gestwicki; Ann Kuo; Kryn Stankunas; Isabella A Graef; Gerald R Crabtree Journal: Cell Date: 2004-09-03 Impact factor: 41.582
Authors: Leslie F Jackson; Ting Hu Qiu; Susan W Sunnarborg; Aileen Chang; Chunlian Zhang; Cam Patterson; David C Lee Journal: EMBO J Date: 2003-06-02 Impact factor: 11.598
Authors: Yukiko Sugi; Naoki Ito; Györgyi Szebenyi; Kioina Myers; John F Fallon; Takashi Mikawa; Roger R Markwald Journal: Dev Biol Date: 2003-06-15 Impact factor: 3.582
Authors: Frederik J de Lange; Antoon F M Moorman; Robert H Anderson; Jörg Männer; Alexandre T Soufan; Corrie de Gier-de Vries; Michael D Schneider; Sandra Webb; Maurice J B van den Hoff; Vincent M Christoffels Journal: Circ Res Date: 2004-08-05 Impact factor: 17.367
Authors: Kartik Balachandran; Patrick W Alford; Jill Wylie-Sears; Josue A Goss; Anna Grosberg; Joyce Bischoff; Elena Aikawa; Robert A Levine; Kevin Kit Parker Journal: Proc Natl Acad Sci U S A Date: 2011-11-28 Impact factor: 11.205
Authors: Robert A Levine; Albert A Hagége; Daniel P Judge; Muralidhar Padala; Jacob P Dal-Bianco; Elena Aikawa; Jonathan Beaudoin; Joyce Bischoff; Nabila Bouatia-Naji; Patrick Bruneval; Jonathan T Butcher; Alain Carpentier; Miguel Chaput; Adrian H Chester; Catherine Clusel; Francesca N Delling; Harry C Dietz; Christian Dina; Ronen Durst; Leticia Fernandez-Friera; Mark D Handschumacher; Morten O Jensen; Xavier P Jeunemaitre; Hervé Le Marec; Thierry Le Tourneau; Roger R Markwald; Jean Mérot; Emmanuel Messas; David P Milan; Tui Neri; Russell A Norris; David Peal; Maelle Perrocheau; Vincent Probst; Michael Pucéat; Nadia Rosenthal; Jorge Solis; Jean-Jacques Schott; Ehud Schwammenthal; Susan A Slaugenhaupt; Jae-Kwan Song; Magdi H Yacoub Journal: Nat Rev Cardiol Date: 2015-10-20 Impact factor: 32.419
Authors: Joyce Bischoff; Guillem Casanovas; Jill Wylie-Sears; Dae-Hee Kim; Philipp E Bartko; J Luis Guerrero; Jacob P Dal-Bianco; Jonathan Beaudoin; Michael L Garcia; Suzanne M Sullivan; Margo M Seybolt; Brittan A Morris; Joshua Keegan; Whitney S Irvin; Elena Aikawa; Robert A Levine Journal: Circ Res Date: 2016-10-06 Impact factor: 17.367
Authors: Laura E Briggs; Aimee L Phelps; Elizabeth Brown; Jayant Kakarla; Robert H Anderson; Maurice J B van den Hoff; Andy Wessels Journal: Circ Res Date: 2013-04-12 Impact factor: 17.367
Authors: Tara A Burns; Raymond N Deepe; John Bullard; Aimee L Phelps; Katelynn A Toomer; Emilye Hiriart; Russell A Norris; Courtney J Haycraft; Andy Wessels Journal: Anat Rec (Hoboken) Date: 2018-10-05 Impact factor: 2.064